<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2677931-A1" country="EP" doc-number="2677931" kind="A1" date="20140101" family-id="45774184" file-reference-id="316853" date-produced="20180826" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146551706" ucid="EP-2677931-A1"><document-id><country>EP</country><doc-number>2677931</doc-number><kind>A1</kind><date>20140101</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-12706536-A" is-representative="NO"><document-id mxw-id="PAPP154825629" load-source="docdb" format="epo"><country>EP</country><doc-number>12706536</doc-number><kind>A</kind><date>20120223</date><lang>EN</lang></document-id><document-id mxw-id="PAPP220439799" load-source="docdb" format="original"><country>EP</country><doc-number>12706536.5</doc-number><date>20120223</date><lang>EN</lang></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140447520" ucid="EP-2012053049-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>2012053049</doc-number><kind>W</kind><date>20120223</date></document-id></priority-claim><priority-claim mxw-id="PPC140449669" ucid="US-201113032672-A" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>201113032672</doc-number><kind>A</kind><date>20110223</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1988096960" load-source="docdb">A61B   5/145       20060101AFI20120914BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-1632738855" load-source="docdb" scheme="CPC">G06F  19/00        20130101 LI20180607BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1713575078" load-source="docdb" scheme="CPC">G16H  40/63        20180101 LI20180103BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2117095316" load-source="docdb" scheme="CPC">A61B   5/14532     20130101 FI20150113BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2117104980" load-source="docdb" scheme="CPC">A61B   5/743       20130101 LI20150113BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2117105087" load-source="docdb" scheme="CPC">A61B   5/7275      20130101 LA20150113BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132187602" lang="DE" load-source="patent-office">VORRICHTUNG UND VERFAHREN ZUR BESTIMMUNG VON BLUTZUCKEIGENSCHAFTEN</invention-title><invention-title mxw-id="PT132187603" lang="EN" load-source="patent-office">DEVICE AND METHOD FOR DETERMINING BLOOD GLUCOSE CHARACTERISTICS</invention-title><invention-title mxw-id="PT132187604" lang="FR" load-source="patent-office">DISPOSITIF ET PROCÉDÉ POUR DÉTERMINER DES CARACTÉRISTIQUES DE GLYCÉMIE</invention-title></technical-data><parties><applicants><applicant mxw-id="PPAR918155258" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>ROCHE DIAGNOSTICS GMBH</last-name><address><country>DE</country></address></addressbook></applicant><applicant mxw-id="PPAR918143213" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>ROCHE DIAGNOSTICS GMBH</last-name></addressbook></applicant><applicant mxw-id="PPAR918983390" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Roche Diagnostics GmbH</last-name><iid>101223946</iid><address><street>Sandhofer Strasse 116</street><city>68305 Mannheim</city><country>DE</country></address></addressbook></applicant><applicant mxw-id="PPAR918146290" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>HOFFMANN LA ROCHE</last-name><address><country>CH</country></address></addressbook></applicant><applicant mxw-id="PPAR918159191" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>F.HOFFMANN-LA ROCHE AG</last-name></addressbook></applicant><applicant mxw-id="PPAR918985022" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>F.HOFFMANN-LA ROCHE AG</last-name><iid>100120526</iid><address><street>Grenzacherstrasse 124</street><city>4070 Basel</city><country>CH</country></address></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR918153076" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>WERNER KARL</last-name><address><country>DE</country></address></addressbook></inventor><inventor mxw-id="PPAR918165887" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>WERNER, KARL</last-name></addressbook></inventor><inventor mxw-id="PPAR918991880" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>WERNER, KARL</last-name><address><street>Friedenspfad 14</street><city>69168 Wiesloch</city><country>DE</country></address></addressbook></inventor><inventor mxw-id="PPAR918139383" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>BLASBERG PETER</last-name><address><country>DE</country></address></addressbook></inventor><inventor mxw-id="PPAR918157538" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>BLASBERG, PETER</last-name></addressbook></inventor><inventor mxw-id="PPAR918978646" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>BLASBERG, PETER</last-name><address><street>Hammeltrogweg 16</street><city>69469 Weinheim</city><country>DE</country></address></addressbook></inventor></inventors><agents><agent mxw-id="PPAR918984121" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Bittner, Thomas L.</last-name><iid>100045424</iid><address><street>Boehmert &amp; Boehmert Pettenkoferstrasse 20-22</street><city>80336 München</city><country>DE</country></address></addressbook></agent></agents></parties><international-convention-data><pct-or-regional-filing-data ucid="EP-2012053049-W"><document-id><country>EP</country><doc-number>2012053049</doc-number><kind>W</kind><date>20120223</date><lang>EN</lang></document-id></pct-or-regional-filing-data><pct-or-regional-publishing-data ucid="WO-2012113852-A1"><document-id><country>WO</country><doc-number>2012113852</doc-number><kind>A1</kind><date>20120830</date><lang>EN</lang></document-id></pct-or-regional-publishing-data><designated-states><ep-contracting-states><country mxw-id="DS548923852" load-source="docdb">AL</country><country mxw-id="DS548869358" load-source="docdb">AT</country><country mxw-id="DS548923853" load-source="docdb">BE</country><country mxw-id="DS548938078" load-source="docdb">BG</country><country mxw-id="DS548935631" load-source="docdb">CH</country><country mxw-id="DS548947277" load-source="docdb">CY</country><country mxw-id="DS548869359" load-source="docdb">CZ</country><country mxw-id="DS548818185" load-source="docdb">DE</country><country mxw-id="DS548947278" load-source="docdb">DK</country><country mxw-id="DS548947279" load-source="docdb">EE</country><country mxw-id="DS548841354" load-source="docdb">ES</country><country mxw-id="DS548938079" load-source="docdb">FI</country><country mxw-id="DS548938080" load-source="docdb">FR</country><country mxw-id="DS548923854" load-source="docdb">GB</country><country mxw-id="DS548947280" load-source="docdb">GR</country><country mxw-id="DS548923855" load-source="docdb">HR</country><country mxw-id="DS548869360" load-source="docdb">HU</country><country mxw-id="DS548935632" load-source="docdb">IE</country><country mxw-id="DS548923856" load-source="docdb">IS</country><country mxw-id="DS548938081" load-source="docdb">IT</country><country mxw-id="DS548947281" load-source="docdb">LI</country><country mxw-id="DS548818186" load-source="docdb">LT</country><country mxw-id="DS548869361" load-source="docdb">LU</country><country mxw-id="DS548818187" load-source="docdb">LV</country><country mxw-id="DS548818188" load-source="docdb">MC</country><country mxw-id="DS548939405" load-source="docdb">MK</country><country mxw-id="DS548939406" load-source="docdb">MT</country><country mxw-id="DS548869362" load-source="docdb">NL</country><country mxw-id="DS548923857" load-source="docdb">NO</country><country mxw-id="DS548869363" load-source="docdb">PL</country><country mxw-id="DS548818189" load-source="docdb">PT</country><country mxw-id="DS548869364" load-source="docdb">RO</country><country mxw-id="DS548818194" load-source="docdb">RS</country><country mxw-id="DS548869365" load-source="docdb">SE</country><country mxw-id="DS548818195" load-source="docdb">SI</country><country mxw-id="DS548947282" load-source="docdb">SK</country><country mxw-id="DS548947283" load-source="docdb">SM</country><country mxw-id="DS548939407" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data><office-specific-data><eptags><ep-no-a-document-published>*</ep-no-a-document-published></eptags></office-specific-data></bibliographic-data><abstract mxw-id="PA99625523" ref-ucid="WO-2012113852-A1" lang="EN" load-source="patent-office"><p num="0000">The invention relates to a device for determining blood glucose characteristics, comprising a sensor input (1) capable of receiving a signal from a sensor (5), the signal being based on a sensed blood glucose value of a user, a memory (3), configured for storing measurements of the sensed blood glucose value of the user, a display (4), configured for presenting a graphical representation the measurements of the blood glucose characteristic value, and a controller (2), configured for controlling the presentation of the graphical representation on the display, wherein the graphical representation comprises a trend indicator indicating an approximate value trend in the sensed blood glucose value over a recent series of measurements, and wherein the trend indicator comprises a plurality of graphical segments, each being of different graphical style and assigned to a different range of sensed blood glucose values, thereby indicating a transition from a first range to a second range of sensed blood glucose values. Furthermore, the invention relates to a method for operating a device for determining blood glucose characteristics.</p></abstract><abstract mxw-id="PA99824042" ref-ucid="WO-2012113852-A1" lang="EN" source="national office" load-source="docdb"><p>The invention relates to a device for determining blood glucose characteristics, comprising a sensor input (1) capable of receiving a signal from a sensor (5), the signal being based on a sensed blood glucose value of a user, a memory (3), configured for storing measurements of the sensed blood glucose value of the user, a display (4), configured for presenting a graphical representation the measurements of the blood glucose characteristic value, and a controller (2), configured for controlling the presentation of the graphical representation on the display, wherein the graphical representation comprises a trend indicator indicating an approximate value trend in the sensed blood glucose value over a recent series of measurements, and wherein the trend indicator comprises a plurality of graphical segments, each being of different graphical style and assigned to a different range of sensed blood glucose values, thereby indicating a transition from a first range to a second range of sensed blood glucose values. Furthermore, the invention relates to a method for operating a device for determining blood glucose characteristics.</p></abstract><abstract mxw-id="PA99625524" ref-ucid="WO-2012113852-A1" lang="FR" load-source="patent-office"><p num="0000">La présente invention concerne un dispositif pour déterminer des caractéristiques de glycémie, comprenant une entrée de capteur (1) pouvant recevoir un signal depuis un capteur (5), le signal étant basé sur une valeur de glycémie détectée d'un utilisateur, une mémoire (3) configurée pour stocker des mesures d'une valeur de glycémie détectée de l'utilisateur, un affichage (4) configuré pour présenter une représentation graphique des mesures de la valeur caractéristique de glycémie, et un dispositif de commande (2) configuré pour commander la présentation de la représentation graphique sur l'affichage, la représentation graphique comprenant un indicateur de tendance indiquant une tendance de valeur approximative de la valeur de glycémie détectée sur une série de mesures récentes, et l'indicateur de tendance comprenant une pluralité de segments graphiques, chacun étant d'un style graphique différent et affecté à une plage différente de valeurs de glycémie détectées, de manière à indiquer une transition d'une première plage vers une deuxième plage de valeurs de glycémie détectées. De plus, l'invention concerne un procédé pour actionner un dispositif pour déterminer les caractéristiques de glycémie.</p></abstract><abstract mxw-id="PA99824043" ref-ucid="WO-2012113852-A1" lang="FR" source="national office" load-source="docdb"><p>La présente invention concerne un dispositif pour déterminer des caractéristiques de glycémie, comprenant une entrée de capteur (1) pouvant recevoir un signal depuis un capteur (5), le signal étant basé sur une valeur de glycémie détectée d'un utilisateur, une mémoire (3) configurée pour stocker des mesures d'une valeur de glycémie détectée de l'utilisateur, un affichage (4) configuré pour présenter une représentation graphique des mesures de la valeur caractéristique de glycémie, et un dispositif de commande (2) configuré pour commander la présentation de la représentation graphique sur l'affichage, la représentation graphique comprenant un indicateur de tendance indiquant une tendance de valeur approximative de la valeur de glycémie détectée sur une série de mesures récentes, et l'indicateur de tendance comprenant une pluralité de segments graphiques, chacun étant d'un style graphique différent et affecté à une plage différente de valeurs de glycémie détectées, de manière à indiquer une transition d'une première plage vers une deuxième plage de valeurs de glycémie détectées. De plus, l'invention concerne un procédé pour actionner un dispositif pour déterminer les caractéristiques de glycémie.</p></abstract><description mxw-id="PDES50931282" ref-ucid="WO-2012113852-A1" lang="EN" load-source="patent-office"><!-- EPO <DP n="3"/>--><p id="p0001" num="0001"> Device and method for determining blood glucose characteristics </p><p id="p0002" num="0002">The present invention refers to a device for determining blood glucose characteristics and method. </p><p id="p0003" num="0003">Background </p><p id="p0004" num="0004">Such technologies are used in order to determine characteristics of patients' measured blood glucose values. The objective is to give the patient as well as the attending medical staff in- formation which enables the patient to deal with his blood glucose values in an improved and appropriate manner. </p><p id="p0005" num="0005">For people suffering from diabetes, in particular Diabetes Mellitus, it is especially important for them to keep their blood glucose values constantly at a particular level. A precondition for this is knowledge of their blood glucose value which is therefore measured using a blood glucose measuring device set up for this purpose. Blood glucose measuring devices are known in various embodiments. </p><p id="p0006" num="0006">The international standard way of measuring blood glucose levels are in terms of a molar concentration, measured in mmol / 1 (millimoles per litre, or millimolar, abbreviated mM). In some countries, mass concentration is measured in mg / dl (milligrams per decilitre). Since the molecular weight of glucose C6H12O6 is about 180 g / mol, for the measurement of glucose, the difference between the two scales is a factor of 18, so that 1 mmol / 1 of glucose is equivalent to 18 mg / dl. </p><p id="p0007" num="0007">If it is determined, on the basis of the measured values, that the blood glucose value has exceeded the recommended level, medicine is administered, for example by means of insulin injection or the oral administration of Metformin, an oral antidiabeticum. If the blood glucose values fall below the ideal or recommended level, sugar must be orally ingested, for example through food or drink. If the ideal level is exceeded for an extended period of time, there is the danger of serious health complications such as blindness, kidney damage, limbs having to be amputated or neuropathy. If the exceeding of the prescribed blood glucose level is for a short time only but considerable, this can lead to nausea, dizziness, sweating or even condi- 
<!-- EPO <DP n="4"/>-->
 tions of confusion. Thus, it is particularly important for a diabetic to know his blood glucose values at all times so that he is able to implement the appropriate measures to avoid the blood sugar values deviating from the ideal levels. A blood glucose measuring device with which the blood glucose values of diabetics can be measured is known, for example from the document US 2007 / 0293790 Al and is sold by the applicant under the registered trade mark, Accu-Chek. </p><p id="p0008" num="0008">It is known, blood glucose measurements can be made according to a continuous measure- ment regime. Such measurements are also known as CGM measurements (Continuous Monitoring blood Glucose Measurement). In this process, the blood glucose values are measured continuously in a continuous time period such that, for example, the progress of the blood glucose value can be collected over an entire day. The analysis of the measured blood glucose values can provide for the determination of several day trends. In this way it is possible to determine blood glucose fluctuations dependent on the time of day. A disadvantage of the continuous blood glucose measurements is firstly, due to the continuous measurements, it can lead to high costs and secondly that it leads to discomfort for the diabetic whereby the latter is caused by the permanent wearing of a subcutaneous sensor. This can lead to infections at the point of entry, intolerance of the plaster or skin irritation which prevents the device being worn permanently or for a long period of time, for example several months. A continuous measurement of the blood glucose values is described, for example, in the document, Gross et al, "Performance Evaluation of the MiniMed Continuous Glucose Monitoring System During Patient Home Use", Diabetes Technology &amp; Therapeutics, 2 (2000)49. In connection with the continuous monitoring of blood glucose values, the proposal is made in the document US 2008 / 0287755 Al, to perform a so-called trend analysis. This can enable the rate of change to be determined on the basis of two or more blood glucose value measurements. The period of continuously monitoring can be between 5 and 30 minutes. Measurement periods of less than 10 minutes or more than 30 minutes can be provided. Within the measurement period, the CGM measurement is performed once per second or once per minute whereby constant or variable cycle lengths can be provided. The known method proposes that the trend thus determined can be presented on a display as a directional arrow. 
<!-- EPO <DP n="5"/>-->
 Furthermore, discontinuous or structured blood glucose measurements are known which are especially also known as SMBG measurements (Self Monitoring Blood Glucose Measurement) and are characterised by the fact that blood glucose values are determined at particular time intervals by means of individual measurements and / or series of measurements. In this way, it is possible, with the help of such blood glucose measurements, which are also known as structured blood glucose measurements, to measure blood glucose values in close proximity to particular events, for example in relation to meals. Disadvantages of structured blood glucose measurement can arise if events relevant for the blood glucose value of the diabetic occur between the measurement times so that they are undetectable. In the document US 2009 / 0054753 Al, a procedure is described whereby an individual blood glucose measurement in the scope of a discontinuous measurement is used to determine the time for a subsequent further individual measurement according to certain parameters. The parameters take into account patient and environmental conditions. Also, it was proposed to graphically present measurement related information. Examples can be found in US 2007 / 0066873 Al, US 2008 / 0021666 Al, US 2008 / 0255438 Al, US 2009 / 0043525 Al, and US 7,399,277 B2. For graphical representation of measurement related information it was proposed to present a trend arrow which may appear on a display showing measurement results for warning the user. Trend arrows with different orientation were used to show different conditions: sharp rise, rise, little or no change, fall, or sharp fall of a current blood sugar level compared to last blood test (Accu-Check Instant DM, Diabetes Management System, user's manual, Boehringer Mannheim Corporation, 1996). </p><p id="p0009" num="0009">Summary of the invention </p><p id="p0010" num="0010">It is the object of the invention to provide a device for determining blood glucose characteristics and a method with improved user handling. </p><p id="p0011" num="0011">According to the invention a device for determining blood glucose characteristics and a method for operating a device for determining blood glucose characteristics according to claims 1 and 9, respectively, are provided. Advantageous developments of the invention are disclosed in dependent claims. 
<!-- EPO <DP n="6"/>-->
 According to one aspect of the invention, a device for determining blood glucose characteristics is provided, comprising a sensor input capable of receiving a signal from a sensor, the signal being based on a sensed blood glucose value of a user, a memory, configured for storing a plurality of measurements of the sensed blood glucose value of the user from the re- ceived signal from the sensor, a display, configured for presenting a graphical representation of the plurality of measurements of the blood glucose characteristic value, and a controller, configured for controlling the presentation of the graphical representation on the display, wherein the graphical representation comprises a trend indicator indicating an approximate value trend in the sensed blood glucose value over a recent series of the plurality of measure- ments, and wherein the trend indicator comprises a plurality of graphical segments, each of the graphical segments being of different graphical style and assigned to a different range of sensed blood glucose values, thereby indicating a transition from a first range of sensed blood glucose values to second range of sensed blood glucose values. </p><p id="p0012" num="0012">According to another aspect of the invention, a method for operating a device for determining blood glucose characteristics is provided, the method comprising steps of receiving a signal from a sensor by a sensor input, the signal being based on a sensed blood glucose value of a user, storing a plurality of measurements of the sensed blood glucose value of the user from the received signal from the sensor in a memory, presenting a graphical representation of the plurality of measurements of the blood glucose characteristic value on a display, and controlling the presentation of the graphical representation on the display by a controller, wherein the step of presenting the graphical representation further comprises a step presenting a trend indicator indicating an approximate value trend in the sensed blood glucose value over a recent series of the plurality of measurements, the trend indicator comprising a plurality of graphical segments, each of the graphical segments being of different graphical style and assigned to a different range of sensed blood glucose values, thereby for sensed blood glucose value indicating a transition from a first range of sensed blood glucose values to second range of sensed blood glucose values. With the help of the invention, the proper operation of the device for determining blood glucose characteristics is improved. The possibility has been provided for the user not only to be able to find out the blood glucose value itself but also to be informed about the trend of the value over time which is derived from the comparison of at least two blood glucose measurements. Depending on whether a rise or a drop or a stability of the blood glucose value is de- 
<!-- EPO <DP n="7"/>-->
 termined, this is shown on the display with the help of the trend indicator. The graphical trend indicator enables the user to quickly comprehend a situation regarding his blood glucose level. By the invention, it is possible, preferably in the scope of discontinuous blood glucose measurements to provide the patient and / or medical staff information as to the time related changes of the measured blood glucose values. The time related changes can show an increase or rise, decrease or drop or constant level of blood glucose values. The information about the time related changes, namely the trend of blood glucose values can preferably be determined in the form of a positive or negative slope which corresponds to an increase or decrease. If no time related change in the blood glucose levels is determined, there is no slope. </p><p id="p0013" num="0013">The trend indicator is comprised of a plurality of graphical segments which differ in respect of the graphical style used for the display. The differing graphical segments are allocated or assigned to different ranges of sensed blood glucose values. Such a range can cover several possible measurement values or just one. Due to the fact that the trend indicator is comprised of a plurality of different graphical segments, one or more transitions between different ranges of sensed blood glucose values can thus be displayed. If, for example, the trend indicator comprises two graphical segments, the trend indicator will, on the one hand show the trend, namely a rise or drop, for example through variation in the slope of the graphical element. Furthermore, with the help of the graphical segments, which are displayed with differing graphic styles, information is also displayed as to the two ranges between which the transition has occurred. For example, it can be provided that a first graphical segment which relates to a blood glucose value between 4.0 and 5.5 mmol / 1 is displayed in a first colour in the trend indicator. If a later measurement value reveals that this value now lies in another range, for example between 5.5 and 7 mmol / 1, the trend indicator with be shown with a graphical segment in a second colour. In this example, the trend indicator shows, on the one hand, a rise, for example with the help of an appropriate arrowhead. In addition, the user can see at a glance between which two ranges the transition occurred as a result of the rise. </p><p id="p0014" num="0014">According to an embodiment, for the graphical segments different graphical styles are selected from the following group of graphic styles: color style and shading style. It can also be provided that two graphical segments differ both in color style and shading style. 
<!-- EPO <DP n="8"/>-->
 In a further embodiment, the controller is configured to perform a time analysis for determining a measurement time for an early measurement providing a first sensed blood glucose value assigned to the first range of sensed blood glucose values and a later measurement providing a second sensed blood glucose value assigned to the second range of sensed blood glucose values, and prevent the graphical representation of the trend indicator on the display if from the time analysis one of the following conditions is concluded: a time interval between the early and the later measurement is shorter than a minimum time interval, and the time interval between the early and the later measurement is longer than a maximum time interval. In this embodiment it is also provided that, in addition to the trend analysis, the time interval be- tween the measurements can be analyzed in order to determine the blood glucose values from which the graphically displayed trend indicator was derived. The representation of the trend indicator is prevented by the controller if the time interval is shorter than a particular minimum length. The representation of the trend indicator is also prevented if the time interval is too long. The values for the minimum and maximum time interval can be set by the user or predefined by the device. In this way, a trend display is prevented in situations where a trend cannot be determined properly for the respective blood glucose values due to a too long or too short interval between the measurements. </p><p id="p0015" num="0015">According to still a further preferred embodiment, the trend indicator is indicating a trend mode for the sensed blood glucose values selected from the following group: moderate drop, moderate rise, steep drop, and steep rise. The differentiation between steep and moderate can be realized, for example through the trend indicator being displayed as a vertical or diagonal arrow whereby a vertical arrow would show a steep change either a rise or a drop. In another preferred embodiment, a device integrated sensor is provided. In this embodiment the device is provided with the sensor itself. Devices for determining blood glucose characteristics based on a test element analysis are known as such in different configurations, e.g. from US 2007 / 0293790 Al . In still another preferred embodiment, the graphical representation comprises a warning symbol indicating that a recent blood glucose value of the sensed blood glucose value belongs to a risk situation. A risk situation may be determined by the controller by evaluating at least one of the following: sensed blood glucose value(s), trend of the blood glucose values, extrapola- 
<!-- EPO <DP n="9"/>-->
 tion for future blood glucose value, time interval information for measurements of the blood glucose value, day time information and injected bolus information. </p><p id="p0016" num="0016">With respect to the method for operating a device for determining blood glucose characteris- tics, preferred embodiments may be provided as described in detail for the device above. </p><p id="p0017" num="0017">Description of preferred embodiments </p><p id="p0018" num="0018">In the following, the invention will be described in further detail, by way of example, with reference to different embodiments. The figures show: </p><p id="p0019" num="0019"> Fig. 1 a schematic representation of device for determining blood glucose characteristics, and Fig. 2 a schematic representation of presentations on a display of the device in Fig. 1. </p><p id="p0020" num="0020">Fig. 1 shows a schematic representation of a device for determining blood glucose value char- acteristics with a sensor input 1, a controller 2 and a memory 3. The controller 2 is connected to a display 4 in order to control the representation of the graphical elements on the display 4. In the case of the embodiment shown in Fig. 1, a sensor 5 is shown as an external sensor configured to measure blood glucose value characteristics for a user. The preferred method for sensing blood glucose values is a discontinuous mode. In another embodiment, the sensor 5 can be integrated into the device, represented in Fig. 1 as a dashed line. For example, this would then by a device for determining blood glucose with the help of so-called test strips, whereby a blood sample is applied to the test strips in order to determine the blood glucose value. The signals sensed by the sensor 5 to the sensor input 1 on the respective blood glucose value characteristics, are then processed by the controller 2 in order to generate controlling signals for the display 4, in particular to display graphical elements which represent the blood glucose values and / or information pertaining to changes per time unit (trend). Fig. 2 shows a schematic representation of presentations to be shown on the display 4. In the embodiment shown, the display 4 shows a present blood glucose value 20 as well as date information 21. Furthermore, a trend indicator 22 is shown which, in the embodiment shown, has the form of an arrow. The trend indicator 22 comprises, in each of the two representations in Fig. 2, two different graphical segments 23, 24 which differ in terms of the shading used. 
<!-- EPO <DP n="10"/>-->
 The first graphical segment 23 shows, through means of its graphical style, that the starting point selected for the trend analysis was in an initial range of blood glucose values, for example in a range between 3.5 and 5 mmol / 1. The later value for the trend analysis, in the upper representation in Fig. 2, lies in another range of blood glucose values which is expressed in the second graphical segment 24 by way of the lack of shading. For example, the range here covers blood glucose values between 6 and 8 mmol / 1. The slope of the arrow displayed in the upper representation in Fig. 2 indicates a moderate rise in the blood glucose value in the time period analyzed. </p><p id="p0021" num="0021">In contrast, the trend indicator 22 in the lower representation in Fig. 2, shows a steep drop derived from the blood glucose values measured for the trend analysis. In the lower representation in Fig. 2, the graphical segments 23, 24 also differ in respect of their shading and thus show that the steep drop led to a transition from one range of blood glucose values to another range of blood glucose values. </p><p id="p0022" num="0022">The graphical segment at the arrowhead 25 shows with its graphical style, the range in which the previous blood glucose value used for the trend analysis has fallen. The graphical segment at the arrowhead 26 of the trend indicator 22, shows, by means of its graphical style, the range into which the blood glucose values of the later blood glucose value used for the trend analysis has fallen. </p><p id="p0023" num="0023">It can also be provided that the trend indicator 22 comprises more than two different graphical segments which differ in terms of their graphic style. </p><p id="p0024" num="0024">Referring to Fig. 1, a warning symbol 27 is presented on the display 4. The warning indicates that the present blood glucose value is in a critical range of blood glucose values. The controller 2 will generate control signals for displaying the warning symbol 27 depending on predefined rules which may be adapted by the user. The following rules may be applied: </p><p id="p0025" num="0025">- measured blood glucose value is &lt; 60 mg / dl; </p><p id="p0026" num="0026"> - measured blood glucose value is &gt; 300 mg / dl; </p><p id="p0027" num="0027"> - measured blood glucose value was taken after main meal AND previous blood glucose value was before main meal AND extrapolated blood glucose value in two hours is &lt; 90 mg / dl OR extrapolated blood glucose value in two hours is &gt; 300 mg / dl; 
<!-- EPO <DP n="11"/>-->
 - measured blood glucose value was taken before main meal AND previous blood glucose value was taken after main meal AND extrapolated blood glucose value in 1 hour is &lt; 60 mg / dl OR extrapolated blood glucose value in one hour is &gt; 250 mg / dl; </p><p id="p0028" num="0028"> - none of the above mentioned information about meal relation AND extrapolated blood glucose value in 2 hours is &lt; 60 mg / dl OR extrapolated blood glucose value in two hours is &gt; 300 mg / dl; </p><p id="p0029" num="0029"> - measured blood glucose value is &lt; 60 mg / dl AND blood glucose value was &lt; 60 mg / dl at same time (23 hours &lt; time interval &lt; 25 hours) on the previous day; </p><p id="p0030" num="0030"> - measured blood glucose value is &gt; 100 mg / dl AND hypo symptoms are entered; </p><p id="p0031" num="0031"> - measured blood glucose value is &lt; 50 mg / dl AND no hypo symptoms are set; or </p><p id="p0032" num="0032"> - measured blood glucose value is outside (below / above) a target range AND the same blood glucose value trend happened the day before (same blood glucose value - blood glucose value difference &lt; 20 mg /dl AND difference in slopes &lt; ± 9 mg / dl * h AND difference in time of day &lt; ± 1 hour AND both values taken before or after main meal). </p><p id="p0033" num="0033">The features disclosed in this specification, the figures and / or the claims may be material for the realization of the invention in its various embodiments, taken in isolation or in various combinations thereof. 
</p></description><claims mxw-id="PCLM44727236" ref-ucid="WO-2012113852-A1" lang="EN" load-source="patent-office"><claim id="clm-0001" num="0001"><!-- EPO <DP n="12"/>--><claim-text/><claim-text>Claims </claim-text><claim-text>A device for determining blood glucose characteristics, comprising: </claim-text><claim-text> - a sensor input (1) capable of receiving a signal from a sensor (5), the signal being based on a sensed blood glucose value of a user, </claim-text><claim-text> - a memory (3), configured for storing a plurality of measurements of the sensed blood glucose value of the user from the received signal from the sensor, </claim-text><claim-text> - a display (4), configured for presenting a graphical representation of the plurality of measurements of the blood glucose characteristic value, and </claim-text><claim-text> - a controller (2), configured for controlling the presentation of the graphical representation on the display, </claim-text><claim-text>wherein the graphical representation comprises a trend indicator (22) indicating an approximate value trend in the sensed blood glucose value over a recent series of the plurality of measurements, and </claim-text><claim-text>wherein the trend indicator (22) comprises a plurality of graphical segments (23, 24), each of the graphical segments (23, 24) being of different graphical style and assigned to a different range of sensed blood glucose values, thereby indicating a transition from a first range of sensed blood glucose values to second range of sensed blood glucose values. </claim-text><claim-text>Device according to claim 1, wherein for the graphical segments (23, 24) different graphical styles are selected from the following group of graphic styles: color style and shading style. </claim-text><claim-text>Device according to claim 1 or 2, wherein the controller (2) is configured to </claim-text><claim-text> - perform a time analysis for determining a measurement time for an early measurement providing a first sensed blood glucose value assigned to the first range of sensed blood glucose values and a later measurement providing a second sensed blood glucose value assigned to the second range of sensed blood glucose values, and </claim-text><claim-text> - prevent the graphical representation of the trend indicator (22) on the display (4) if from the time analysis one of the following conditions is concluded: </claim-text><claim-text> - a time interval between the early and the later measurement is shorter than a minimum time interval, and 
<!-- EPO <DP n="13"/>-->
 - the time interval between the early and the later measurement is longer than a maximum time interval. </claim-text><claim-text>Device according to claim 1, wherein the trend indicator is indicating (22) a trend mode for the sensed blood glucose values selected from the following group: moderate drop, moderate rise, steep drop, and steep rise. </claim-text><claim-text>Device according to claim 1, wherein a device integrated sensor is provided. </claim-text><claim-text>Device according to claim 5, wherein the device integrated sensor is configured to sense the blood glucose values from a test element analysis. </claim-text><claim-text>Device according to claim 1, wherein the sensed blood glucose values are provided from a discontinuous mode of blood glucose measurement. </claim-text><claim-text>Device according to claim 1, wherein the graphical representation comprises a warning symbol (27) indicating that a recent blood glucose value of the sensed blood glucose value belongs to a risk situation. </claim-text><claim-text>A method for operating a device for determining blood glucose characteristics, the method comprising steps of: </claim-text><claim-text> - receiving a signal from a sensor (5) by a sensor input (1), the signal being based on a sensed blood glucose value of a user, </claim-text><claim-text> - storing a plurality of measurements of the sensed blood glucose value of the user from the received signal from the sensor in a memory (3), </claim-text><claim-text> - presenting a graphical representation of the plurality of measurements of the blood glucose characteristic value on a display (4), and </claim-text><claim-text> - controlling the presentation of the graphical representation on the display by a control- ler (2), </claim-text><claim-text>wherein the step of presenting the graphical representation further comprises a step presenting a trend indicator (22) indicating an approximate value trend in the sensed blood glucose value over a recent series of the plurality of measurements, the trend indicator (22) comprising a plurality of graphical segments (23, 24), each of the graphical segments 
<!-- EPO <DP n="14"/>-->
 (23) being of different graphical style and assigned to a different range of sensed blood glucose values, thereby for sensed blood glucose value indicating a transition from a first range of sensed blood glucose values to second range of sensed blood glucose values. 
</claim-text></claim></claims><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
